US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

CALCIMEDICA

1.50

-0.0250-1.64%

Post-market: 1.500.00000.00%18:27 EDT

Volume:20.39K

Turnover:30.75K

Market Cap:20.22M

PE:-1.23

High:1.53

Open:1.49

Low:1.48

Close:1.53

Loading ...

Overview Company News Filings

CalciMedica Announces Presentations at Upcoming Medical Meetings

CalciMedica Price Target Maintained With a $16.00/Share by HC Wainwright & Co.

CalciMedica to Participate in the Jones Healthcare and Technology Innovation Conference

CalciMedica Inc reports results for the quarter ended December 31 - Earnings Summary

BRIEF-Calcimedica Reports 2024 Financial Results And Provides Clinical & Corporate Updates

CalciMedica Inc - Cash Position Expected to Fund Operations Into Mid-2026

THOMSON REUTERS

CalciMedica Reports 2024 Financial Results and Provides Clinical & Corporate Updates

THOMSON REUTERS

CalciMedica Reports 2024 Financial Results and Provides Clinical & Corporate Updates

Calendar of U.S. Earnings Expected in the Week Ahead

CalciMedica Inc expected to post a loss of 35 cents a share - Earnings Preview

Calendar of U.S. Earnings Expected in the Week Ahead

Promising Phase 2 Results and Market Potential Drive Buy Rating for CalciMedica’s Auxora

Oppenheimer Keeps Their Buy Rating on CalciMedica (CALC)

CalciMedica Shares Drop After Securing New Credit Facility

BRIEF-CalciMedica Secures Credit Facility For Up To $32.5 Million

CalciMedica Secures Credit Facility for up to $32.5 Million

THOMSON REUTERS

CalciMedica Inc - Cash Position Expected to Fund Operations Into Mid-2026

THOMSON REUTERS

CalciMedica Secures Credit Facility for Up to $32.5 Million

CalciMedica Price Target Maintained With a $16.00/Share by HC Wainwright & Co.

CalciMedica Presents AKI Data from a Post-Hoc Analysis of the Phase 2 CARDEA trial of Auxora™ in Severe COVID-19 Pneumonia at the 30th International AKI & CRRT Conference

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/CALC/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"CALC","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"CALC\",,,,,undefined,":{"symbol":"CALC","market":"US","secType":"STK","nameCN":"CALCIMEDICA","latestPrice":1.5,"timestamp":1745611200000,"preClose":1.525,"halted":0,"volume":20392,"hourTrading":{"tag":"盘后","latestPrice":1.5,"preClose":1.5,"latestTime":"18:27 EDT","volume":62,"amount":95.78,"timestamp":1745620053916},"delay":0,"floatShares":5397734,"shares":13481917,"eps":-1.21822,"marketStatus":"Market Closed","change":-0.025,"latestTime":"04-25 16:00:00 EDT","open":1.485,"high":1.53,"low":1.475,"amount":30753.0487696,"amplitude":0.036066,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-1.21822,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1745827200000},"marketStatusCode":7,"adr":0,"listingDate":1601006400000,"exchange":"NASDAQ","adjPreClose":1.525,"postHourTrading":{"tag":"盘后","latestPrice":1.5,"preClose":1.5,"latestTime":"18:27 EDT","volume":62,"amount":95.78,"timestamp":1745620053916},"volumeRatio":0.8766378955072321},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"CALC\",,,,,undefined,":{"symbol":"CALC","floatShares":5397734,"roa":"-94.61%","roe":"-121.42%","lyrEps":-1.21822,"volumeRatio":0.8766378955072321,"shares":13481917,"dividePrice":0,"high":1.53,"amplitude":0.036066,"preClose":1.525,"low":1.475,"week52Low":1.43,"pbRate":"1.40","week52High":6.265,"institutionHeld":0,"latestPrice":1.5,"eps":-1.21822,"divideRate":0,"volume":20392,"delay":0,"ttmEps":-1.21822,"open":1.485,"prevYearClose":3.54,"prevWeekClose":1.55,"prevMonthClose":1.91,"prevQuarterClose":1.91,"fiveDayClose":1.55,"twentyDayClose":2.07,"sixtyDayClose":2.63},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"CALC\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2528163716","title":"CalciMedica Announces Presentations at Upcoming Medical Meetings","url":"https://stock-news.laohu8.com/highlight/detail?id=2528163716","media":"PR Newswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2528163716?lang=en_us&edition=fundamental","pubTime":"2025-04-17 19:00","pubTimestamp":1744887600,"startTime":"0","endTime":"0","summary":"LA JOLLA, Calif., April 17, 2025 /PRNewswire/ -- CalciMedica Inc.  , a clinical-stage biopharmaceutical company focused on developing novel calcium release-activated calcium  channel inhibition therapies for acute and chronic inflammatory and immunologic illnesses, today announced the acceptance of an abstract for poster presentation at Digestive Disease Week  2025 being held May 3-6 in San Diego, CA, and the participation of Sudarshan Hebbar, M.D., Chief Medical Officer ofCalciMedica, in both an oral presentation and a panel discussion at the American Society of Nephrology  3rd Acute Kidney Injury: From Bench to Bedside Conference being held May 4-7 in Leesburg, VA.Presentation Title: Patients with Acute Pancreatitis  and Accompanying Systemic Inflammatory Response Syndrome  Have a Larger Volume of Distribution Compared to Healthy Volunteers. Presenter: Kenneth A. Stauderman, Ph.D., co-Founder and Chief Scientific Officer ofCalciMedica. Session Date and Time: Saturday,May 3, 12:30-1:3","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"yahoofinance","url":"https://finance.yahoo.com/news/calcimedica-announces-presentations-upcoming-medical-110000162.html","rn_cache_url":null,"customStyle":"img, svg { display: none !important; }","selectors":"article","filters":"","directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/calcimedica-announces-presentations-upcoming-medical-110000162.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4007","AP","BK4006","CALC"],"gpt_icon":0},{"id":"2524919244","title":"CalciMedica Price Target Maintained With a $16.00/Share by HC Wainwright & Co.","url":"https://stock-news.laohu8.com/highlight/detail?id=2524919244","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2524919244?lang=en_us&edition=fundamental","pubTime":"2025-04-01 19:25","pubTimestamp":1743506700,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/CALC/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  April 01, 2025 07:25 ET (11:25 GMT)","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CALC"],"gpt_icon":0},{"id":"2524675115","title":"CalciMedica to Participate in the Jones Healthcare and Technology Innovation Conference","url":"https://stock-news.laohu8.com/highlight/detail?id=2524675115","media":"PR Newswire","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2524675115?lang=en_us&edition=fundamental","pubTime":"2025-04-01 19:00","pubTimestamp":1743505200,"startTime":"0","endTime":"0","summary":"LA JOLLA, Calif., April 1, 2025 /PRNewswire/ -- CalciMedica Inc.  , a clinical-stage biopharmaceutical company focused on developing novel calcium release-activated calcium  channel inhibition therapies for acute and chronic inflammatory and immunologic illnesses, today announced that Rachel Leheny, Ph.D., Chief Executive Officer, will present at the Jones Healthcare and Technology Innovation Conference on Wednesday, April 9, 2025, at 11:00 a.m. PT.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"yahoofinance","url":"https://finance.yahoo.com/news/calcimedica-participate-jones-healthcare-technology-110000465.html","rn_cache_url":null,"customStyle":"img, svg { display: none !important; }","selectors":"article","filters":"","directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/calcimedica-participate-jones-healthcare-technology-110000465.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["CALC","BK4007","BK4006","BK4137","AP","HCSG"],"gpt_icon":0},{"id":"2522374604","title":"CalciMedica Inc reports results for the quarter ended December 31 - Earnings Summary","url":"https://stock-news.laohu8.com/highlight/detail?id=2522374604","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522374604?lang=en_us&edition=fundamental","pubTime":"2025-03-27 19:50","pubTimestamp":1743076208,"startTime":"0","endTime":"0","summary":"CalciMedica Inc reports results for the quarter ended December 31 - Earnings SummaryCalciMedica Inc CALC.OQ reported a quarterly adjusted loss of 38 cents per share for the quarter ended December 31, ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250327:nL5N3QA0YV:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CALC"],"gpt_icon":0},{"id":"2522750523","title":"BRIEF-Calcimedica Reports 2024 Financial Results And Provides Clinical & Corporate Updates","url":"https://stock-news.laohu8.com/highlight/detail?id=2522750523","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522750523?lang=en_us&edition=fundamental","pubTime":"2025-03-27 19:10","pubTimestamp":1743073856,"startTime":"0","endTime":"0","summary":"BRIEF-Calcimedica Reports 2024 Financial Results And Provides Clinical & Corporate UpdatesMarch 27 (Reuters) - CalciMedica Inc CALC.O:CALCIMEDICA REPORTS 2024 FINANCIAL RESULTS AND PROVIDES CLINICAL &","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250327:nTUAVBBBS:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","CALC"],"gpt_icon":0},{"id":"2522375504","title":"CalciMedica Inc - Cash Position Expected to Fund Operations Into Mid-2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2522375504","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522375504?lang=en_us&edition=fundamental","pubTime":"2025-03-27 19:00","pubTimestamp":1743073203,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250327:nTUAVBBBS:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","CALC"],"gpt_icon":0},{"id":"2522375379","title":"CalciMedica Reports 2024 Financial Results and Provides Clinical & Corporate Updates","url":"https://stock-news.laohu8.com/highlight/detail?id=2522375379","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522375379?lang=en_us&edition=fundamental","pubTime":"2025-03-27 19:00","pubTimestamp":1743073203,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250327:nTUAVBBBS:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","CALC"],"gpt_icon":0},{"id":"2522714803","title":"CalciMedica Reports 2024 Financial Results and Provides Clinical & Corporate Updates","url":"https://stock-news.laohu8.com/highlight/detail?id=2522714803","media":"PR Newswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522714803?lang=en_us&edition=fundamental","pubTime":"2025-03-27 19:00","pubTimestamp":1743073200,"startTime":"0","endTime":"0","summary":"Enrollment ongoing in Phase 2KOURAGE trial of Auxora in acute kidney injury  and respiratory failure; data expected around the end of 2025. Post-hoc analysis of subset of patients with AKI in the Phase 2 CARDEA trial of Auxora in severe COVID-19 pneumonia showed a 62.7% relative reduction in mortality at day 30, which persisted through day 60, for patients treated with Auxora versus placebo. Cash position expected to fund operations into mid-2026. LA JOLLA, Calif., March 27, 2025 /PRNewswire/ -- CalciMedica Inc.  , a clinical-stage biopharmaceutical company focused on developing novel calcium release-activated calcium  channel inhibition therapies for acute and chronic inflammatory and immunologic illnesses, today reported financial results for the year ended December 31, 2024 and provided clinical and corporate updates.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"yahoofinance","url":"https://finance.yahoo.com/news/calcimedica-reports-2024-financial-results-110000200.html","rn_cache_url":null,"customStyle":"img, svg { display: none !important; }","selectors":"article","filters":"","directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/calcimedica-reports-2024-financial-results-110000200.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4213","CALC","BK4585","LU0256331488.USD","BK4007","APA","BK4588","AP","BK4006"],"gpt_icon":0},{"id":"2522329609","title":"Calendar of U.S. Earnings Expected in the Week Ahead","url":"https://stock-news.laohu8.com/highlight/detail?id=2522329609","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522329609?lang=en_us&edition=fundamental","pubTime":"2025-03-27 18:00","pubTimestamp":1743069600,"startTime":"0","endTime":"0","summary":"Major companies tentatively scheduled to report quarterly earnings in the week ahead, with earnings estimates provided by FactSet Research Systems Inc.·INmune Bio Inc.                                 4Q      (.55)  4:05 PM. ·TD SYNNEX Corp                                   1Q      2.91   8:05 AM","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IKT","LULU","NNOX","PVH","SDST","BCAB","LNZA","TLSI","NUTX","PVLA","FTCI","GWH","PENG","BRZE","FC","FEMY","FBIO","BW","RLMD","TSAT","RANI","BLRX","WBA","SGML","SLRN","INMB","AFMD","GEVO","ANGO","NCNO","DARE","CLSD","EDAP","INR","REKR","BHST","WGO","ATAI","MDAI","PRGS","GOVX","SPWH","SKYH","WKSP","KYTX","CRDL","UNCY","CALC","ADCT","CELC"],"gpt_icon":0},{"id":"2521723367","title":"CalciMedica Inc  expected to post a loss of 35 cents a share - Earnings Preview","url":"https://stock-news.laohu8.com/highlight/detail?id=2521723367","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2521723367?lang=en_us&edition=fundamental","pubTime":"2025-03-24 20:33","pubTimestamp":1742819586,"startTime":"0","endTime":"0","summary":"CalciMedica Inc  expected to post a loss of35cents a share - Earnings Preview CalciMedica Inc CALC.OQ CALC.O is expected to show no change in quarterly revenue when it reports  results on March 26 (es","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250324:nL5N3Q70XO:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CALC"],"gpt_icon":0},{"id":"2521714099","title":"Calendar of U.S. Earnings Expected in the Week Ahead","url":"https://stock-news.laohu8.com/highlight/detail?id=2521714099","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2521714099?lang=en_us&edition=fundamental","pubTime":"2025-03-24 18:00","pubTimestamp":1742810400,"startTime":"0","endTime":"0","summary":"Major companies tentatively scheduled to report quarterly earnings in the week ahead, with earnings estimates provided by FactSet Research Systems Inc.·Comp de San Bas                                  4Q       .36       AMC. ·Oklo Inc. Class A                               4Q      (.07)      AMC. ·Core & Main Inc.                                 4Q       .36       BMO. ·McCormick & Co                                 1Q       .64   6:30 AM","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["THRD","PAYS","SDST","BEEM","RVPH","FBIO","PDSB","DERM","MREO","CNXC","BCAB","WOOF","LPTX","SCS","IKT","XFOR","SURG","ANTX","MLKN","PAYX","OBIO","ACRV","GOVX","MKC","CALC","WBA","AFMD","WGO","NUTX","CRMD","SKYX","EDAP","SLRN","RLMD","CDLR","GRDN","MDAI","KOD","IVA","ABL","IOBT","CLSD","CTAS","KBH","DLTR","UNCY","ZURA","CHWY","ALUR","TEN"],"gpt_icon":0},{"id":"2517270178","title":"Promising Phase 2 Results and Market Potential Drive Buy Rating for CalciMedica’s Auxora","url":"https://stock-news.laohu8.com/highlight/detail?id=2517270178","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517270178?lang=en_us&edition=fundamental","pubTime":"2025-03-07 14:55","pubTimestamp":1741330540,"startTime":"0","endTime":"0","summary":"CalciMedica (CALC – Research Report), the Healthcare sector company, was revisited by a Wall Street analyst on March 4. Analyst Joseph Pantginis fr...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/promising-phase-2-results-and-market-potential-drive-buy-rating-for-calcimedicas-auxora?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/promising-phase-2-results-and-market-potential-drive-buy-rating-for-calcimedicas-auxora?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4007","CALC"],"gpt_icon":0},{"id":"2517577661","title":"Oppenheimer Keeps Their Buy Rating on CalciMedica (CALC)","url":"https://stock-news.laohu8.com/highlight/detail?id=2517577661","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517577661?lang=en_us&edition=fundamental","pubTime":"2025-03-06 21:26","pubTimestamp":1741267583,"startTime":"0","endTime":"0","summary":"In a report released today, Leland Gershell from Oppenheimer reiterated a Buy rating on CalciMedica (CALC – Research Report), with a price target o...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/oppenheimer-keeps-their-buy-rating-on-calcimedica-calc?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate","earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/oppenheimer-keeps-their-buy-rating-on-calcimedica-calc?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["OPY","CALC"],"gpt_icon":0},{"id":"2517472559","title":"CalciMedica Shares Drop After Securing New Credit Facility","url":"https://stock-news.laohu8.com/highlight/detail?id=2517472559","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517472559?lang=en_us&edition=fundamental","pubTime":"2025-03-06 01:47","pubTimestamp":1741196820,"startTime":"0","endTime":"0","summary":"CalciMedica shares were down 5%, to $2.16, after the company said it has entered into a credit facility with Avenue Venture Opportunities Fund II, a fund of Avenue Capital Group, providing up to $32.5 million.The biopharmaceutical company said proceeds from the facility are intended to support the continued development of its product pipeline.The credit agreement, which has a term of 3 1/2 years, includes an initial tranche of $10 million fully funded at close and additional tranches of up to $22.5 million available to the company subject to certain milestones.There is no minimum cash requirement, nor other financial covenants, in the agreement. With the proceeds from the first tranche of this facility, CalciMedica's cash position is expected to fund current operations into the middle of 2026.CalciMedica shares hit their 52-week low of $1.86 Tuesday, and are down 53% in the past 12 months.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CALC","BK4007"],"gpt_icon":0},{"id":"2517162119","title":"BRIEF-CalciMedica Secures Credit Facility For Up To $32.5 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2517162119","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517162119?lang=en_us&edition=fundamental","pubTime":"2025-03-05 20:44","pubTimestamp":1741178698,"startTime":"0","endTime":"0","summary":"BRIEF-CalciMedica Secures Credit Facility For Up To $32.5 MillionMarch 5 (Reuters) - CalciMedica CALC.O:CALCIMEDICA SECURES CREDIT FACILITY FOR UP TO $32.5 MILLIONCALCIMEDICA INC - CASH POSITION EXPEC","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250305:nTUA2QGBLB:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","CALC"],"gpt_icon":0},{"id":"2517991395","title":"CalciMedica Secures Credit Facility for up to $32.5 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2517991395","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517991395?lang=en_us&edition=fundamental","pubTime":"2025-03-05 20:00","pubTimestamp":1741176006,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250305:nTUA2QGBLB:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["CALC","BK4007"],"gpt_icon":0},{"id":"2517791301","title":"CalciMedica Inc - Cash Position Expected to Fund Operations Into Mid-2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2517791301","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517791301?lang=en_us&edition=fundamental","pubTime":"2025-03-05 20:00","pubTimestamp":1741176006,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250305:nTUA2QGBLB:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","CALC"],"gpt_icon":0},{"id":"2517491913","title":"CalciMedica Secures Credit Facility for Up to $32.5 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2517491913","media":"PR Newswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517491913?lang=en_us&edition=fundamental","pubTime":"2025-03-05 20:00","pubTimestamp":1741176000,"startTime":"0","endTime":"0","summary":"$10 million funded at close extends cash runway into mid-2026. LA JOLLA, Calif., March 5, 2025 /PRNewswire/ -- CalciMedica Inc.  , a clinical-stage biopharmaceutical company focused on developing novel calcium release-activated calcium  channel inhibition therapies for acute and chronic inflammatory and immunologic illnesses, today announced that the Company has entered into a credit facility with Avenue Venture Opportunities Fund II, L.P., a fund of Avenue Capital Group, providing up to $32.5 million. Proceeds from the facility are intended to support the continued development of the Company's product pipeline.\"Avenue welcomes this opportunity to support CalciMedica in its mission to deliver treatments to patients with high unmet need,\" said Chad Norman, Senior Portfolio Manager of Avenue Venture Opportunities Fund. \"We appreciate the potential of its lead pipeline candidate, Auxora, to treat acute inflammatory and immunologic diseases and look forward to its continued progress in cli","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"yahoofinance","url":"https://finance.yahoo.com/news/calcimedica-secures-credit-facility-32-120000258.html","rn_cache_url":null,"customStyle":"img, svg { display: none !important; }","selectors":"article","filters":"","directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/calcimedica-secures-credit-facility-32-120000258.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["CALC","BK4007","BK4006","AP"],"gpt_icon":0},{"id":"2516679565","title":"CalciMedica Price Target Maintained With a $16.00/Share by HC Wainwright & Co.","url":"https://stock-news.laohu8.com/highlight/detail?id=2516679565","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2516679565?lang=en_us&edition=fundamental","pubTime":"2025-03-04 21:29","pubTimestamp":1741094940,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/CALC/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  March 04, 2025 08:29 ET (13:29 GMT)","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CALC"],"gpt_icon":0},{"id":"2516620121","title":"CalciMedica Presents AKI Data from a Post-Hoc Analysis of the Phase 2 CARDEA trial of Auxora™ in Severe COVID-19 Pneumonia at the 30th International AKI & CRRT Conference","url":"https://stock-news.laohu8.com/highlight/detail?id=2516620121","media":"PR Newswire","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2516620121?lang=en_us&edition=fundamental","pubTime":"2025-03-04 20:00","pubTimestamp":1741089600,"startTime":"0","endTime":"0","summary":"LA JOLLA, Calif., March 4, 2025 /PRNewswire/ -- CalciMedica Inc.  , a clinical-stage biopharmaceutical company focused on developing novel calcium release-activated calcium  channel inhibition therapies for acute and chronic inflammatory and immunologic illnesses, today announcedthat Sudarshan Hebbar, M.D., Chief Medical Officer of CalciMedica, delivered a plenary presentation at the 30th International Acute Kidney Injury and Continuous Renal Replacement Therapy Conference  on March 3, 2025 in San Diego, CA. The presentation outlined the role of CRAC channels in acute kidney injury  pathophysiology and included new data highlighting the potential of CalciMedica's lead product candidate, Auxora, in AKI. CalciMedica is currently conducting a Phase 2 trial of Auxora in patients with Stage 2 or Stage 3 AKI and acute hypoxemic respiratory failure, which is expected to read out in 2025.In clinical trial biomarker studies, CARDEA patients who received Auxora versus placebo had","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"yahoofinance","url":"https://finance.yahoo.com/news/calcimedica-presents-aki-data-post-120000286.html","rn_cache_url":null,"customStyle":"img, svg { display: none !important; }","selectors":"article","filters":"","directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/calcimedica-presents-aki-data-post-120000286.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4551","AP","BK4006","BK4568","BK4212","CALC","BK4535","BK4585","POST","BK4588","BK4548","BNTX","BK4007","BK4139"],"gpt_icon":0}],"pageSize":20,"totalPage":3,"pageCount":1,"totalSize":55,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/CALC\",params:#limit:5,,,undefined,":[{"market":"US","date":"2025-03-27","symbol":"CALC","fiscalQuarterEnding":"2024/12","expectedEps":-0.48,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1743048000000,"reportTimeType":"pre","actualEps":-0.34},{"market":"US","date":"2024-11-13","symbol":"CALC","fiscalQuarterEnding":"2024/09","expectedEps":-0.61,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1731474000000,"reportTimeType":"pre","actualEps":-0.5},{"market":"US","date":"2024-08-12","symbol":"CALC","fiscalQuarterEnding":"2024/06","expectedEps":-0.55,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1723435200000,"reportTimeType":"post","actualEps":-0.52},{"market":"US","date":"2024-05-13","symbol":"CALC","fiscalQuarterEnding":"2024/03","expectedEps":-0.5,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1715572800000,"reportTimeType":"post","actualEps":-0.43},{"market":"US","date":"2024-03-28","symbol":"CALC","fiscalQuarterEnding":"2023/12","expectedEps":1,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1711598400000,"reportTimeType":"pre","actualEps":-0.23}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"CALC\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"CALC\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.25,"buy":0.75,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.75,"analysts":4,"updateTime":1734494400000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/CALC\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"CALC","date":"2025-04-25","current":-1.500724,"percent":0.863636,"low":-4.525842,"twenty":-3.555775,"median":-2.72853,"eighty":-1.652383,"high":-0.644854,"avg":-2.618509,"sd":0.960529,"marketCap":20559923},"quantilePoints":[{"date":"2024-01-05","current":-0.71129,"twenty":-0.71129,"median":-0.71129,"eighty":-0.71129,"marketCap":20480891},{"date":"2024-01-12","current":-0.644854,"twenty":-0.706809,"median":-0.663373,"eighty":-0.661399,"marketCap":18567932},{"date":"2024-01-19","current":-0.842346,"twenty":-0.707705,"median":-0.673245,"eighty":-0.662978,"marketCap":24254510},{"date":"2024-01-26","current":-1.017241,"twenty":-1.012132,"median":-0.706809,"eighty":-0.663373,"marketCap":29290430},{"date":"2024-02-02","current":-2.31259,"twenty":-1.35801,"median":-0.893146,"eighty":-0.671271,"marketCap":66588713},{"date":"2024-02-09","current":-1.906022,"twenty":-2.088582,"median":-1.017241,"eighty":-0.673245,"marketCap":54881987},{"date":"2024-02-16","current":-1.682223,"twenty":-2.119115,"median":-1.116267,"eighty":-0.690619,"marketCap":48437918},{"date":"2024-02-23","current":-1.643058,"twenty":-2.095833,"median":-1.634666,"eighty":-0.702071,"marketCap":47310206},{"date":"2024-03-01","current":-1.633733,"twenty":-2.020905,"median":-1.643058,"eighty":-0.709498,"marketCap":47041703},{"date":"2024-03-08","current":-1.652383,"twenty":-1.962717,"median":-1.659843,"eighty":-0.789924,"marketCap":47578709},{"date":"2024-03-15","current":-1.626273,"twenty":-1.923926,"median":-1.652383,"eighty":-0.903305,"marketCap":46826901},{"date":"2024-03-22","current":-1.428584,"twenty":-1.903784,"median":-1.64026,"eighty":-0.984091,"marketCap":41134640},{"date":"2024-03-28","current":-1.309808,"twenty":-1.864992,"median":-1.631159,"eighty":-1.013409,"marketCap":45001081},{"date":"2024-04-05","current":-1.359825,"twenty":-1.759493,"median":-1.626273,"eighty":-1.046819,"marketCap":46719500},{"date":"2024-04-12","current":-1.378581,"twenty":-1.683991,"median":-1.551673,"eighty":-1.099979,"marketCap":47363907},{"date":"2024-04-19","current":-1.25354,"twenty":-1.680731,"median":-1.469614,"eighty":-1.115647,"marketCap":43067861},{"date":"2024-04-26","current":-1.653672,"twenty":-1.680731,"median":-1.452232,"eighty":-1.163031,"marketCap":56815208},{"date":"2024-05-03","current":-1.87562,"twenty":-1.717206,"median":-1.540483,"eighty":-1.238535,"marketCap":64440690},{"date":"2024-05-10","current":-1.766209,"twenty":-1.764959,"median":-1.622543,"eighty":-1.25479,"marketCap":60681649},{"date":"2024-05-17","current":-3.903797,"twenty":-1.803163,"median":-1.628585,"eighty":-1.259167,"marketCap":58318824},{"date":"2024-05-24","current":-3.709686,"twenty":-1.90453,"median":-1.64026,"eighty":-1.263536,"marketCap":55418993},{"date":"2024-05-31","current":-4.076341,"twenty":-2.061189,"median":-1.652383,"eighty":-1.269686,"marketCap":60896452},{"date":"2024-06-07","current":-3.763144,"twenty":-2.28275,"median":-1.667303,"eighty":-1.292545,"marketCap":56217609},{"date":"2024-06-14","current":-3.626433,"twenty":-2.775108,"median":-1.674763,"eighty":-1.30043,"marketCap":54175287},{"date":"2024-06-21","current":-3.741558,"twenty":-3.626433,"median":-1.678493,"eighty":-1.306682,"marketCap":55895138},{"date":"2024-06-28","current":-2.266521,"twenty":-3.626433,"median":-1.678493,"eighty":-1.308558,"marketCap":33859554},{"date":"2024-07-05","current":-3.0652,"twenty":-3.626433,"median":-1.678493,"eighty":-1.309808,"marketCap":45791016},{"date":"2024-07-12","current":-3.396184,"twenty":-3.511308,"median":-1.683696,"eighty":-1.342725,"marketCap":50735586},{"date":"2024-07-15","current":-3.518504,"twenty":-3.517065,"median":-1.685169,"eighty":-1.342739,"marketCap":52562927},{"date":"2024-08-02","current":-3.223823,"twenty":-3.515626,"median":-1.694429,"eighty":-1.342753,"marketCap":48160698},{"date":"2024-08-09","current":-3.346156,"twenty":-3.502674,"median":-1.717881,"eighty":-1.345855,"marketCap":49988225},{"date":"2024-08-16","current":-3.501123,"twenty":-3.583261,"median":-1.750157,"eighty":-1.351697,"marketCap":44075639},{"date":"2024-08-23","current":-3.569438,"twenty":-3.582315,"median":-1.766209,"eighty":-1.354811,"marketCap":44935652},{"date":"2024-08-30","current":-3.67191,"twenty":-3.613882,"median":-1.801693,"eighty":-1.356667,"marketCap":46225670},{"date":"2024-09-06","current":-4.397752,"twenty":-3.637946,"median":-1.869368,"eighty":-1.357299,"marketCap":55363303},{"date":"2024-09-13","current":-3.552359,"twenty":-3.65203,"median":-1.906022,"eighty":-1.362326,"marketCap":44720648},{"date":"2024-09-20","current":-3.53528,"twenty":-3.640824,"median":-2.030976,"eighty":-1.373579,"marketCap":44505645},{"date":"2024-09-27","current":-3.859775,"twenty":-3.700214,"median":-2.125233,"eighty":-1.378581,"marketCap":48590705},{"date":"2024-10-04","current":-3.740224,"twenty":-3.708962,"median":-2.289556,"eighty":-1.380457,"marketCap":47085683},{"date":"2024-10-11","current":-3.371069,"twenty":-3.708962,"median":-2.722888,"eighty":-1.392648,"marketCap":42438390},{"date":"2024-10-18","current":-3.381146,"twenty":-3.700214,"median":-2.935837,"eighty":-1.41484,"marketCap":42565242},{"date":"2024-10-25","current":-3.53528,"twenty":-3.675822,"median":-3.058004,"eighty":-1.429837,"marketCap":44505645},{"date":"2024-10-31","current":-4.098876,"twenty":-3.6768,"median":-3.0652,"eighty":-1.43485,"marketCap":51600748},{"date":"2024-11-08","current":-3.744979,"twenty":-3.72195,"median":-3.072551,"eighty":-1.469614,"marketCap":47145546},{"date":"2024-11-15","current":-3.340773,"twenty":-3.734279,"median":-3.223823,"eighty":-1.536753,"marketCap":45394425},{"date":"2024-11-22","current":-3.420079,"twenty":-3.72195,"median":-3.270562,"eighty":-1.540483,"marketCap":46472038},{"date":"2024-11-29","current":-3.423065,"twenty":-3.714694,"median":-3.298285,"eighty":-1.558387,"marketCap":46512613},{"date":"2024-12-06","current":-2.966657,"twenty":-3.710325,"median":-3.295449,"eighty":-1.607623,"marketCap":40310931},{"date":"2024-12-13","current":-2.768218,"twenty":-3.706791,"median":-3.249448,"eighty":-1.624781,"marketCap":37614548},{"date":"2024-12-20","current":-2.748374,"twenty":-3.682653,"median":-3.194715,"eighty":-1.626273,"marketCap":37344910},{"date":"2024-12-27","current":-2.986501,"twenty":-3.673866,"median":-3.079903,"eighty":-1.62766,"marketCap":40580570},{"date":"2025-01-03","current":-3.264315,"twenty":-3.665078,"median":-3.095642,"eighty":-1.630644,"marketCap":44355506},{"date":"2025-01-10","current":-2.976579,"twenty":-3.653123,"median":-3.165095,"eighty":-1.634479,"marketCap":40445751},{"date":"2025-01-17","current":-3.145251,"twenty":-3.645198,"median":-3.087772,"eighty":-1.638582,"marketCap":42737676},{"date":"2025-01-24","current":-2.867437,"twenty":-3.640824,"median":-3.065538,"eighty":-1.643058,"marketCap":38962740},{"date":"2025-01-31","current":-2.52017,"twenty":-3.640824,"median":-3.058004,"eighty":-1.652383,"marketCap":34244069},{"date":"2025-02-07","current":-2.688843,"twenty":-3.640824,"median":-3.04842,"eighty":-1.652383,"marketCap":36535995},{"date":"2025-02-14","current":-2.649155,"twenty":-3.63798,"median":-3.022334,"eighty":-1.653672,"marketCap":35996718},{"date":"2025-02-21","current":-2.420951,"twenty":-3.628742,"median":-2.996423,"eighty":-1.664577,"marketCap":32895877},{"date":"2025-02-28","current":-2.2622,"twenty":-3.626433,"median":-2.986501,"eighty":-1.670287,"marketCap":30738770},{"date":"2025-03-07","current":-2.182824,"twenty":-3.621826,"median":-2.966657,"eighty":-1.674017,"marketCap":29660217},{"date":"2025-03-14","current":-1.885166,"twenty":-3.613842,"median":-2.897203,"eighty":-1.674763,"marketCap":25615642},{"date":"2025-03-21","current":-2.083605,"twenty":-3.598472,"median":-2.84934,"eighty":-1.677747,"marketCap":28312025},{"date":"2025-03-28","current":-2.053839,"twenty":-3.588224,"median":-2.832711,"eighty":-1.678493,"marketCap":27907568},{"date":"2025-04-04","current":-1.800869,"twenty":-3.578114,"median":-2.788062,"eighty":-1.678493,"marketCap":24671908},{"date":"2025-04-11","current":-1.456441,"twenty":-3.570753,"median":-2.763257,"eighty":-1.678493,"marketCap":19953237},{"date":"2025-04-17","current":-1.515486,"twenty":-3.564314,"median":-2.743413,"eighty":-1.673271,"marketCap":20762152},{"date":"2025-04-25","current":-1.500724,"twenty":-3.555775,"median":-2.72853,"eighty":-1.652383,"marketCap":20559923}],"updateTime":1745662315702}}}